Congress May Have Stalled Out, But States Are Taking on the PBMs

With federal PBM reform mired in gridlock, states are stepping up to tackle the opaque and anticompetitive practices driving up prescription drug costs and shuttering independent pharmacies. This article examines how lawmakers across the country are advancing bold, bipartisan measures to increase transparency, require PBM licensure, ban spread pricing, and curb vertical integration, offering a potential blueprint for future national policy.